NCCTG N1174: Phase I/comparative randomized phase (Ph) II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma (GBM) (Alliance) Meeting Abstract
| Authors: | Galanis, E.; Anderson, S. K.; Butowski, N. A.; Hormigo, A.; Schiff, D.; Tran, D. D.; Omuro, A. M. P.; Jaeckle, K. A.; Kumar, S.; Kaufmann, T. J.; Buckner, J. C.; Twohy, E.; Giannini, C.; Wen, P. Y. |
| Abstract Title: | NCCTG N1174: Phase I/comparative randomized phase (Ph) II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma (GBM) (Alliance) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 91s |
| Language: | English |
| ACCESSION: | WOS:000411895703193 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.2023 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2023 -- Source: Wos |
